NCT06410495

Brief Summary

In this proposal a brief web-based cognitive behavioral treatment for insomnia (CBT-I) for children with oppositional defiant disorder (ODD) and their parents is iteratively adapted and tested for acceptability, feasibility, and preliminary efficacy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2024

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

May 7, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 13, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

March 28, 2025

Status Verified

March 1, 2025

Enrollment Period

1.3 years

First QC Date

May 7, 2024

Last Update Submit

March 24, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Child Daily Sleep Diaries

    Daily diaries filled out by children with parent assistance that measure sleep efficiency, sleep onset latency, and total sleep time. Diaries also measure child behavior.

    Each morning for 14-days at 0 weeks, 6 weeks, and 10 weeks

  • Parent Daily Sleep Diaries

    Daily diaries filled out by parent that measure sleep efficiency, sleep onset latency, and total sleep time. Diaries also measure child behavior.

    Each morning for 14-days at 0 weeks, 6 weeks, and 10 weeks

Secondary Outcomes (14)

  • Child Actigraphy

    24/7 during the 2 week assessment at 0 weeks, 6 weeks, and 10 weeks

  • Parent Actigraphy

    24/7 during the 2 week assessment at 0 weeks, 6 weeks, and 10 weeks

  • Child Heartrate Variability

    during a cold-pressor task at 0 weeks, 6 weeks, 10 weeks

  • Parent Heartrate Variability

    during a cold-pressor task at 0 weeks, 6 weeks, 10 weeks

  • The Revised Childhood Anxiety and Depression Scale

    0 weeks, 6 weeks, 10 weeks

  • +9 more secondary outcomes

Study Arms (1)

NiteCAPP SINCC

EXPERIMENTAL

Content includes both standard CBT-I techniques \[sleep hygiene, stimulus control, sleep restriction, cognitive therapy\] as well as those targeting children with ODD and their parents. Active child participation is a goal but may be limited due to age/abilities. Parents will work with children to implement behavioral strategies.

Behavioral: NiteCAPP SINCC

Interventions

NiteCAPP SINCCBEHAVIORAL

Standard CBT-I techniques along with modules targeting noncompliance in children with ODD and their parents.

NiteCAPP SINCC

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Child ages 8-17 with ODD (prior diagnosis) and insomnia
  • Child and parent English proficiency.
  • Insomnia:
  • complaints of difficulties falling asleep, staying asleep, or early morning awakening by child report or parent observation for 3+ mos
  • daytime dysfunction (mood, cognitive, social, academic) due to insomnia
  • baseline diaries and actigraphy indicate \>30 mins. of sleep onset latency, wake after sleep onset, or early morning awakening (time between last awakening and out of bed time) on 6+ nights

You may not qualify if:

  • Parent unable to provide informed consent or child unable to provide assent
  • Family unwilling to accept random assignment
  • Child/parent participation in another randomized research project
  • Parent unable to complete forms or implement treatment procedures due to cognitive impairment
  • Child untreated medical comorbidity, including other sleep disorders (e.g., apnea, epilepsy, psychotic disorders, suicidal ideation/intent, \[frequent\] parasomnias)
  • Child psychotropic or other medications that alter sleep with the exceptions of stimulants, sleep medications, and/or melatonin
  • Child participation in non-pharmacological treatment (including CBT) for sleep outside current trial
  • Parent report of inability to undergo Holter Monitoring or actigraphy (e.g., extreme sensitivity, behavioral outbursts)
  • Other conditions adversely affecting trial participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of South Florida

Tampa, Florida, 33620-8100, United States

RECRUITING

MeSH Terms

Conditions

Oppositional Defiant DisorderSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental DisordersSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Central Study Contacts

Melanie Stearns, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 7, 2024

First Posted

May 13, 2024

Study Start

May 1, 2024

Primary Completion

August 1, 2025

Study Completion

December 1, 2025

Last Updated

March 28, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations